Episode 10: Dr. Richard Miller on Longevity research and Promising Longevity Drugs to Extend Human Lifespan

Thanks for listening to Backedbriscience. Check out the website at backedbriscience.com or Brian's Instagram @BrianDevorkin.

 

Tune into this episode for the latest longevity studies, and how research is being done in Dr. Miller's world-renowned lab to test the efficacy of drugs for human lifespan extension. 

--

Richard A. Miller, M.D., Ph.D., is a Professor of Pathology at the University of Michigan.  He received his BA degree in 1971 from Haverford College, and MD and PhD degrees from Yale University in 1976-1977. After postdoctoral studies at Harvard and Sloan-Kettering, he began his faculty career at Boston University in 1982 and then moved to his current position at Michigan in 1990. 

 

Dr. Miller has served in a variety of editorial and advisory positions on behalf of the American Federation for Aging Research and the National Institute on Aging, and served as one of the Editors-in-Chief of Aging Cell.  He is the recipient of the Nathan Shock Award, the Allied Signal Award, the Irving Wright Award, an award from the Glenn Foundation, and the Kleemeier Award for aging research. He has been a Senior Scholar of the Ellison Medical Foundation, and is a Fellow of the American Association for the Advancement of Science and a member of the Association of American Physicians.  At Michigan, he directs the Paul F. Glenn Center for Aging Research. 

 

His research program includes ongoing studies of the mechanisms that link stress, nutrients, and hormones to delayed aging in mice, development of new approaches to slow aging and disease through drugs and targeted mutations, and studies of the ways in which cells from long-lived birds, rodents, and primates differ from those of short-lived species.